Publication Name	World Journal of Diabetes
Manuscript ID	24091
Country	China

Received	2016-01-06 17:34
Peer-Review Started	2016-01-09 16:05
To Make the First Decision	2016-03-01 09:12
Return for Revision	2016-03-01 14:50
Revised	2016-03-16 14:35
Second Decision	2016-03-21 08:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-04-06 13:44
Articles in Press	2016-04-06 13:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-19 13:22
Publish the Manuscript Online	2016-04-25 10:30

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Neuroendocrine hormone amylin in diabetes
Manuscript Source	Invited Manuscript
All Author List	Xiao-Xi Zhang, Yan-Hong Pan, Yan-Mei Huang and Hai-Lu Zhao
Funding Agency and Grant Number
Corresponding Author	Hai-Lu Zhao, MD, PhD, Professor, Director, Centre of Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Huan Cheng North 2nd Road 109, Guilin 541004, Guangxi Zhuang Autonomous Region, China. zhaohailu9@126.com
Key Words	Amylin; Neuroendocrine hormone; Diabetes
Core Tip	This is a systematic review to describe amylin as a neuroendocrine hormone. Besides the glucose homeo?stasis and cytotoxicity of amylin, we tried to perform that the S20G mutation of human amylin is also minor in the pathogenesis of diabetes. In addition to the metabolic effects, human amylin may have impact on autoimmunity, implicating a potential as the immunosuppressor to improve autoimmunity conditions in the future therapy of diabetes, allergic diseases and immune rejection.
Publish Date	2016-04-25 10:30
Citation	Zhang XX, Pan YH, Huang YM, Zhao HL. Neuroendocrine hormone amylin in diabetes. World J Diabetes 2016; 7(9): 189-197
URL	http://www.wjgnet.com/1948-9358/full/v7/i9/189.htm
DOI	http://dx.doi.org/10.4239/wjd.v7.i9.189

Full Article (PDF)	WJD-7-189.pdf
Full Article (Word)	WJD-7-189.doc
Manuscript File	24091-Review.doc
Answering Reviewers	24091-Answering reviewers.pdf
Audio Core Tip	24091-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	24091-Conflict-of-interest statement.pdf
Copyright License Agreement	24091-Copyright assignment.pdf
Peer-review Report	24091-Peer-review(s).pdf
Scientific Misconduct Check	24091-Scientific misconduct check.pdf
Scientific Editor Work List	24091-Scientific editor work list.pdf